Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-26 @ 9:56 PM
Study NCT ID:
NCT05607004
Status:
RECRUITING
Last Update Posted:
2025-10-30
First Post:
2022-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Sponsor:
Atossa Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-26
First Submit QC Date:
None
Study First Post Date:
2022-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-29
Last Update Post Date:
2025-10-30
Last Update Post Date Type:
ESTIMATED